AKAnncarol Karanja

Anncarol Karanja

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anncarol Karanja has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Collins Okoyo

    Affiliations Eastern and Southern Africa Centre of International Parasite Control, Kenya Medical Research Institute, Nairobi, Kenya, Department of Epidemiology, Statistics and Informatics, Kenya Medical Research Institute, Nairobi, Kenya

    2 shared publications
  • Edith Chepkorir

    Affiliation Division of Arboviruses and Viral Hemorrhagic Fevers Research, Center for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya

    2 shared publications
  • Francis Mulwa

    Affiliation Division of Arboviruses and Viral Hemorrhagic Fevers Research, Center for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya

    2 shared publications
  • Glennah Kerubo

    Affiliation Department of Microbiology, School of Biochemistry, Microbiology, and Biotechnology, Kenyatta University, Nairobi, Kenya

    2 shared publications
  • Hellen Koka

    Affiliation Division of Arboviruses and Viral Hemorrhagic Fevers Research, Center for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya

    2 shared publications
  • James Mutisya

    Affiliation Division of Arboviruses and Viral Hemorrhagic Fevers Research, Center for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya

    2 shared publications

Latest Publications

  • Open Access

    Tackling the Growing Threat of Multidrug‐Resistant Pseudomonas aeruginosa in Sub‐Saharan Africa: Challenges, Strategies, and the Way Forward

    by Barack Magwi Nyanswi, Ivy J. Mutai, Jael Obiero, Atunga Nyachieo, Anncarol Karanja

    Pseudomonas aeruginosa is a dangerous pathogen that has shown multidrug resistance in Sub‐Saharan Africa (SSA) and has significantly impacted healthcare, where poor infection control and limited resources are common. This narrative review examines strategies in the SSA region to control this pathogen, reports its prevalence, highlights key challenges, and suggests future research. Studies published between 2010 and 2025 in PubMed, Scopus, and Google Scholar, focusing on AMR surveillance, prevalence, infection control, and treatment strategies for AMR P. aeruginosa in SSA, were reviewed. Data were qualitatively and quantitatively summarized and mapped as descriptive median resistance (%) across SSA countries in a geographic heatmap. The results, illustrated in the heatmap, reveal substantial median resistance to common first‐line agents, whereas significant data gaps indicate a critical lack of standardized surveillance in the region. Nations such as South Africa and Kenya have progressed with surveillance and stewardship programs. However, challenges persist in other countries, especially in diagnostics, access to new antibiotics, and infection control. New emerging therapies, including phage therapy and new antibiotics, have shown promise but are limited by regulatory frameworks, costs, and availability. Infection prevention measures are equally weak, resulting in high infection rates due to overcrowding and inadequate hygiene facilities. A more integrated approach that strengthens surveillance, improves infection control, and increases access to novel treatments is needed to combat MDR P. aeruginosa in SSA. Future research must prioritize affordable diagnostics and bridge the “data silence” identified in the regional resistance mapping to address the region′s unique challenges.

  • Open Access

    Genetic diversity of Aedes aegypti populations from Kisumu and Busia counties, western Kenya, and their vector competence for chikungunya virus

    by Victor O. Anyango, Solomon Langat, Francis Mulwa, James Mutisya, Hellen Koka, Collins Okoyo, Edith Chepkorir, Samson Konongoi, Anncarol Karanja, Glennah Kerubo, et al.

    Aedes aegypti (Ae. aegypti) is the primary vector of several arboviruses, including dengue virus (DENV), chikungunya virus (CHIKV), yellow fever virus (YFV), and Zika virus (ZIKV). This vector is widespread globally in tropical and subtropical areas but also found in temperate areas. Kenya experienced its first chikungunya outbreak in Lamu County in 2004, followed by subsequent outbreaks in Mandera in 2016 and Mombasa in 2017. Despite the presence of Ae. aegypti in Kisumu and Busia counties, no outbreaks of chikungunya fever have been reported in these two western Kenya counties. To investigate this phenomenon, we collected Ae. aegypti mosquitoes from the county headquarter towns of Kisumu and Busia. The mosquitoes were reared under controlled laboratory conditions, and their genetic diversity assessed using COI gene sequences. Additionally, neutrality tests, including Tajima’s D and Fu’s FS, were subsequently performed to infer evolutionary dynamics. The mosquitoes were then evaluated for their ability to transmit CHIKV by challenging laboratory-reared F1 generations of field-collected mosquitoes with an infectious blood meal containing CHIKV. Genetic analysis revealed the presence of both Ae. aegypti subspecies, (Ae. aegypti aegypti [Aaa] and Ae. aegypti formosus [Aaf]) in the two western Kenya counties, with Aaf being dominant (19:8 for Kisumu samples and 25:6 for Busia samples). The populations exhibited high haplotype diversity (0.96011 in Kisumu and 0.93763 in Busia) and low nucleotide diversity (0.00913 in Kisumu and 0.00757 in Busia), indicating significant genetic polymorphism at the loci examined. Additionally, negative neutrality tests, including Tajima’s D (-1.87530 for Kisumu and -1.09547 for Busia) and Fu’s FS (-10.223 for Kisumu and -15.249 for Busia), coupled with a smooth mismatch distribution, suggest that recent evolutionary events may have significantly shaped the genetic structure of these populations. The assessment of vector competence of Ae. aegypti populations from Kisumu and Busia counties revealed their capacity to support CHIKV transmission. Specifically, we demonstrated infection, dissemination, and transmission rates of 55.2%, 85.5%, and 27.1% for Kisumu, and 57.8%, 71.8%, and 25% for Busia, respectively. However, statistical analysis indicated no significant difference in vector competence between the two populations. These findings underscore the uniform potential of Ae. aegypti mosquitoes from both Kisumu and Busia to facilitate the spread of CHIKV, highlighting the need for consistent surveillance and vector management strategies across these regions.


  • Open Access

    Genetic variability and vector competence of Aedes aegypti populations from Kisumu and Busia Counties, Western Kenya, for Chikungunya and Zika viruses

    by Victor Okoth Anyango, Solomon Langat, Francis Mulwa, James Mutisya, Hellen Koka, Collins Okoyo, Edith Chepkorir, Samson Konongoi, Anncarol Karanja, Glennah Kerubo, et al.

    Aedes aegypti is the primary vector of several arboviruses, including dengue virus (DENV), chikungunya virus (CHIKV), yellow fever virus (YFV), and Zika virus (ZIKV). This vector is widespread globally in tropical and subtropical areas, but also found in temperate areas. Kenya experienced its first chikungunya outbreaks in Lamu County in 2004 and later in Mandera: 2016, and Mombasa: 2017. While there is yet to be a report of Zika outbreaks in Kenya, sero-surveillance studies indicate low-level transmission of this virus in coastal and northern parts of the country. Despite the presence of Ae. aegypti in Kisumu and Busia counties in sufficient densities, and free movement of people between the coast and the two western Kenya counties, no outbreaks of either disease have been reported in these regions. To investigate this phenomenon, we collected Ae. aegypti mosquitoes from county headquarter towns near railway stations connecting the coast and western Kenya and reared them under controlled laboratory conditions. The mosquitoes were then assessed for genetic variability using CO1 genes as well as their efficiency to transmit viruses using Laboratory colonies (F 1 ) of the field mosquitoes challenged with an infectious blood meal containing CHIKV and ZIKV. Genetic analysis revealed the presence of both Ae. aegypti subspecies, ( Ae. aegypti aegypti [ Aaa ] and Ae. aegypti formosus [ Aaf ]) in the two western Kenya counties, with Aaf being dominant (19:8 for Kisumu samples and 25:6 for Busia samples). Additionally, pairwise comparison revealed minimal genetic differentiation (0.62%) between the study populations, with a high genetic variation (99.38%) observed within each population, indicating significant diversity within individual populations. Ae. aegypti populations from Kisumu and Busia counties exhibited competence for CHIKV, with infection, dissemination, and transmission rates of 55.2%, 85.5%, and 27.1% for Kisumu; and 57.8%, 71.8%, and 25% for Busia populations, respectively. There was no significant difference in vector competence between these two populations. Interestingly, neither population was competent for ZIKV. In conclusion, the data shows that the Ae. aegypti populations in the two cities were homogeneous. This could explain the observed similarity in vector competence for CHIKV and ZIKV. Author Summary: Our study investigated the genetic variability and vector competence of Ae. aegypti mosquito populations in Kisumu and Busia Counties to CHIKV and ZIKV; revealing the presence and even distribution of both Aaa and Aaf subspecies. We also found that the Ae. aegypti populations from the two counties were not genetically differentiated. Furthermore, our study revealed that the Ae. aegypti mosquitoes from Kisumu and Busia counties were competent for CHIKV but may be refractory to ZIKV infection. These findings highlight the importance of continued monitoring of Ae. aegypti populations and their potential for arboviral disease transmission in the region.